You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Small Cell Lung Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in

Active, not recruiting
  • Stage IA Non-Small Cell Lung Carcinoma
  • +3 more
  • Computed Tomography Perfusion Imaging
  • +2 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 5, 2022

NSCLC Trial in Xinxiang (CCCR-NK92 cells)

Enrolling by invitation
  • Non-small Cell Lung Cancer
  • CCCR-NK92 cells
  • Xinxiang, Henan, China
    The first Affiliated Hospital of Xinxiang Medical University
Aug 31, 2022

Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Immune signature in serum associated to the metabolic signature
  • Meta-genomic signature of intestinal flora
  • La Tronche, Isère, France
    University Hospital, Grenoble
Jan 6, 2023

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Small Cell Lung Cancer
    • (no location specified)
    Nov 16, 2022

    Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,

    Recruiting
    • Extensive Stage Small Cell Lung Carcinoma
    • +7 more
    • Scottsdale, Arizona
    • +1 more
    Jun 27, 2022

    Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

    Active, not recruiting
    • Non-Squamous Non-Small Cell Lung Carcinoma
    • +7 more
    • Nivolumab
    • +3 more
    • Abington, Pennsylvania
    • +1 more
    Sep 14, 2022

    EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

    Recruiting
    • EGFR-Mutated Non-Small-Cell Lung Carcinoma
    • Small Cell/Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • ADI-PEG 20
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 14, 2022

    Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

    Recruiting
    • Metastatic Non-small Cell Lung Cancer (NSCLC)
    • +5 more
    • data collection
    • Oldenburg, Germany
      Pius-Hospital
    Jul 20, 2022

    Proteomics in Small Cell Lung Cancer

    Not yet recruiting
    • Small Cell Lung Cancer
      • (no location specified)
      Nov 14, 2022

      Observing Palliative Asymptomatic Centrally Located Advanced

      Active, not recruiting
      • Non-small Cell Lung Carcinoma
      • None: Questionnaire Study
      • Toronto, Ontario, Canada
        University Health Network, Princess Margaret Hospital
      Oct 6, 2022

      Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

      Recruiting
      • Small-cell Lung Cancer
      • Small Cell Lung Carcinoma
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jul 29, 2022

      Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)

      Not yet recruiting
      • Recurrent Extensive Stage Small Cell Lung Carcinoma
      • Hangzhou, China
      • +2 more
      Feb 5, 2023

      Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

      Completed
      Has Results
      • Non-small Cell Lung Carcinoma
      • Pembrolizumab
      • +7 more
      • (no location specified)
      Oct 13, 2022

      Participation for Small Cell Lung Cancer Patients

      Not yet recruiting
      • Small Cell Lung Cancer
        • (no location specified)
        Mar 3, 2023

        Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

        Not yet recruiting
        • Small Cell Lung Cancer Extensive Stage
        • Large Cell Neuroendocrine Carcinoma of the Lung
        • LB2102
        • (no location specified)
        Jan 10, 2023

        Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Trial in

        Recruiting
        • Stage I Non-Small Cell Lung Cancer AJCC v7
        • +6 more
        • Laboratory Biomarker Analysis
        • +3 more
        • Buffalo, New York
          Roswell Park Cancer Institute
        May 2, 2022

        Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)

        Active, not recruiting
        • Small Cell Carcinoma, Hypercalcaemic Type
        • Ovarian Cancer
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jan 8, 2023

        NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

        Active, not recruiting
        • Carcinoma, Non-Small-Cell Lung
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Immune-Connected Assays in Small Cell Lung Cancer

        Recruiting
        • Small Cell Lung Cancer
        • Rome, Italy
          Fondazione Policlinico Gemelli IRCCS
        Apr 2, 2023

        NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))

        Completed
        • Non-small Cell Lung Cancer
        • Melbourne, Victoria, Australia
        • +1 more
        May 23, 2022

        Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)

        Not yet recruiting
        • Small-cell Lung Cancer
        • Small Cell Lung Carcinoma
        • Mycophenolate Mofetil
        • +2 more
        • Saint Louis, Missouri
          Washington University School of Medicine
        May 17, 2022

        Stage I Lung Cancer, Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7 Trial in Atlanta (drug, procedure,

        Active, not recruiting
        • Stage I Lung Cancer
        • +7 more
        • Fludeoxyglucose F-18
        • +2 more
        • Atlanta, Georgia
          Emory University Hospital/Winship Cancer Institute
        Mar 2, 2022

        Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux

        Not yet recruiting
        • Small Cell Lung Cancer
        • +2 more
        • Association of lurbinectedin and durvalumab
        • Association of carboplatin and etoposide
        • Bordeaux, France
          Institut Bergonié
        Oct 5, 2022

        Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)

        Not yet recruiting
        • Small Cell Lung Cancer
        • +2 more
        • (no location specified)
        Nov 27, 2022